毕业于中山大学,浙江省肿瘤医院放射治疗科主治医师。 主持浙江省医药卫生科技平台项目靶向Ⅱ型组织型谷氨酰胺转氨酶(TG2)诱导喉癌放射增敏及其机制研究(2017RC016),主持浙江省肿瘤医院优才基金项目TG2控制剂KCC009对喉癌Hep-2细胞放射增敏作用的实验研究(2012YC003),以第二负责人身份参与自然科学基金面上项目TG2控制剂KCC009增强喉癌细胞放射敏感性的作用机制研究(81372437),浙江省自然科学基金一般项目鼻咽癌患者放射性颞颌关节损伤的动态影像和血清标志物研究(Y16H160124),CSCO-默克雪兰诺肿瘤研究基金(SCORE)项目NRF2抗氧化通路介导鼻咽癌顺铂和耐药的作用机理研究(Y-MT2015-005)。 近年来发表论文共11篇:1 PEI-JING LI WEI-HAN HU TING JIN*.Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.mol clin onc 4: 70-76, 2016 2 TING JIN#, XIAO-ZHONG CHEN# and JIAN-JIANG LIU*, Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma, ONCOLOGY LETTERS, 2015, 10: 1123-1130. 3 Jin T, Zhu Y, Luo JL, Zhou N, Li DC, Ju HX, Fan YT, Liu Y, Zhu YP, Feng HY, Liu LY*, Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer, Int J Colorectal Dis, 2015, 30(3):337-45. 4 Jin T#, Li B#, Chen XZ*, Phase II Trial of Endostar Combined With Gemcitabine and Cisplatin Chemotherapy in Patients With MetastaticNasopharyngeal Carcinoma (NCT01612286), Oncol Res, 2013, 21(6):317-23. 5 Jin T, Lin H, Lin HX, Cai XY, Wang HZ, Hu WH, Guo LB, Zhao JZ*, Treatment and prognosis of patients with recurrent laryngeal carcinoma: a retrospective study, Head Neck Oncol, 2013, 5(2):10. 6 Jin T, Management of the clinically negative neck (N0) of T2N0M0 supraglottic laryngeal carcinoma: A retrospective study, Head Neck Oncol, 2012, 23;4(4):79. 7 Jin T#, Lin HX#, Lin H#, Guo LB#, Ge N, Cai XY, Sun R, Chen WK, Li QL, Hu WH*, Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study, J Transl Med, 2012, 30;10:64. 8 Jin T, Hu WH*, Guo LB, Chen WK, Li QL, Lin H, Cai XY, Ge N, Sun R, Bu SY, Zhang X, Qiu MY, Zhang W, Luo S, Zhou YX, Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma, Chin J Cancer, 2011,30(7):482-9. 9 金厅,胡伟汉,陈晓钟*,组织型谷氨酰胺转氨酶介导的肿瘤细胞化疗耐药的研究进展,肿瘤研究与临床,2013,25 (9): 643-645. 10 金厅,胡伟汉*,林辉,适形调强放射治疗诱发第二原发癌一例,肿瘤研究与临床,2012,24(2):143-144 11 金厅,王芳,胡伟汉*,HIF-1α与VEGF在下咽鳞癌中的表达及其临床意义.中华放射肿瘤学杂志,2011,20(5):385-389。